These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15994914)

  • 1. PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
    Marcucci R; Brogi D; Sofi F; Giglioli C; Valente S; Liotta AA; Lenti M; Gori AM; Prisco D; Abbate R; Gensini GF
    Heart; 2006 Mar; 92(3):377-81. PubMed ID: 15994914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombophilic risk factors for symptomatic peripheral arterial disease.
    Sofi F; Lari B; Rogolino A; Marcucci R; Pratesi G; Dorigo W; Pratesi C; Gensini GF; Abbate R; Prisco D
    J Vasc Surg; 2005 Feb; 41(2):255-60. PubMed ID: 15768007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
    Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
    Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.
    Dalmáz CA; Santos KG; Botton MR; Tedoldi CL; Roisenberg I
    Blood Cells Mol Dis; 2006; 37(2):107-10. PubMed ID: 16963292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm.
    Sofi F; Marcucci R; Giusti B; Pratesi G; Lari B; Sestini I; Lo Sapio P; Pulli R; Pratesi C; Abbate R; Gensini GF
    Thromb Haemost; 2005 Nov; 94(5):1094-8. PubMed ID: 16363254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
    Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
    Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
    Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
    French JK; Van de Water NS; Sutton TM; Lund M; Gao W; McDowell J; Liu-Stratton Y; Pohorence J; Szymanski D; Goldschmidt-Clermont P; White HD; Browett PJ; Cooke G
    Am Heart J; 2003 Jan; 145(1):118-24. PubMed ID: 12514663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined thrombophilic factors among women with late recurrent spontaneous abortions].
    Ivanov P; Komsa-Penkova R; Konova E; Gecheva S; Ivanov I; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2011; 50(3):8-12. PubMed ID: 21916309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
    Zhang AY; Ji XW; Guan LX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.
    Balasa VV; Gruppo RA; Glueck CJ; Stroop D; Becker A; Pillow A; Wang P
    Thromb Haemost; 1999 May; 81(5):739-44. PubMed ID: 10365747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
    Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
    Sartori M; Conti E; Favaretto E; Frascaro M; Legnani C; Palareti G
    Eur J Vasc Endovasc Surg; 2011 Dec; 42(6):817-23. PubMed ID: 21982452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.
    Margaglione M; Cappucci G; Colaizzo D; Giuliani N; Vecchione G; Grandone E; Pennelli O; Di Minno G
    Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):152-6. PubMed ID: 9484978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.